Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections

Br J Haematol. 1997 Feb;96(2):415-7. doi: 10.1046/j.1365-2141.1997.d01-2013.x.

Abstract

We report 13 normal peripheral blood stem cell (PBSC) donors who had a second PBSC collection for allogeneic transplantation performed after the first. The median interval between the first and second collection was 5 months. Mobilization was achieved with filgrastim (12 microg/kg/d). No significant difference was found in the median pre-apheresis leucocyte count (x10(9)/l) between the two donations (40.2 v 38.5; P = 0.91). The median apheresis yield (x10(6) CD34+ cells/litre blood processed, first apheresis) was also similar (28 v 27.3; P = 0.91). Filgrastim-related adverse events were comparable. These data suggest that second PBSC collections are feasible, similarly tolerated and provide comparable apheresis yields.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Blood Component Removal
  • Blood Donors
  • Female
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Leukocyte Count
  • Male
  • Middle Aged
  • Recombinant Proteins
  • Retrospective Studies

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim